News & Media / Press Releases

WBB Securities Co-Manages $84 Million Public Offering for Omeros Corporation

February 4, 2015

WBB Securities acted as co-manager to a transaction for Omeros Corporation in an underwritten public offering that closed on February 3, 2015.

Continue Reading

WBB Securities Co-Manages $10.3MM Public Offering for CytoSorbents Corporation

January 15, 2015

CytoSorbents announces closing of public offering to fund ongoing commercial and clinical activities

Continue Reading

WBB Securities Announces Michelle Thomas Elected to FINRA District 2 Committee

December 8, 2014

WBB Securities is pleased to announce that Michelle Thomas, CRCPhas been elected to the FINRA District 2 Committee where she will serve a three-year term.

Continue Reading

WBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt Facility

September 29, 2014

NeoStem announces $20 million term loan financing from Oxford Finance LLC

Continue Reading

WBB Securities Sponsors BioCentury’s 21st Annual NewsMakers Conference

September 29, 2014

Executive Teams of Emerging Biotech Companies Present to Investor Community

Continue Reading

WBB Securities Acts as Co-manager to TetraLogic Pharmaceuticals on $47MM Convertible Senior Notes Transaction

June 25, 2014

WBB Securities acted as co-manager on a convertible senior notes transaction for TetraLogic Pharmaceuticals, Inc.

Continue Reading

WBB Securities Acts as Exclusive Placement Agent to Cytori Therapeutics

June 6, 2014

WBB Securities acted as exclusive placement agent on a registered direct financing for Cytori Therapeutics, a clinical phase regenerative medicine company.

Continue Reading

WBB Securities Named Co-Manager on Omeros Corporation Underwriting

March 19, 2014

Omeros closes $40.25 million in underwritten public offering

Continue Reading

WBB Securities Retained as Financial Advisor to Athersys, Inc.

January 10, 2014

Athersys announces $20.5 million registered direct financing to fund ongoing clinical trials in regenerative medicine

Continue Reading

WBB Securities Sponsors BioCentury’s 20th Annual NewsMakers Conference

October 1, 2013

Executive Teams of Emerging Biotech Companies to Present to Investor Community

Continue Reading